Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals

$0.625 0.005 (0.81%)

High $0.63	Low $0.59	Trades 32	Turnover $33,720	Volume 55,179
30 June 2023 at 4:10pm

Market Cap (11-Sep) $113,134,928 (718th)	Close (30-Jun) $0.63 0 (0%)	Volume (30-Jun) 55,179	Shortsold (7-Sep) 5,524 (0.00%) (600th)
52w High $0.73	52w Low $0.345	P/E -	EPS -0.05

Short Interest

ASIC data, 7 Sep 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

600th

of 692 shorted ASX stocks

Peak Short

0.37%

Aug 2021

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	RCE RCE Ann: Application for quotation of securities - RCE
	1 (current) 2 3
	RCE RCE Ann: Phase I Clinical Trial of R327 I.V. - 6000mg Complete
	RCE RCE Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RCE RCE Ann: Corporate Presentation - Aussie Equities Day 2022
	RCE RCE Ann: Dr Philip Sutton - V.P. of Translational Sciences
	RCE RCE Ann: Phase I Positive Safety Data - 4000mg Complete
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: Conversion of Performance Shares
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: Phase I Clinical Trial R327 Advances to 4000mg
	RCE RCE Ann: MDC: Biotech Investors Luncheon Presentations
	RCE RCE Ann: Corporate Presentation - Biotech Investor Lunch
	RCE RCE Ann: GTG: Biotech Investors Presentation
	RCE RCE Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: Phase I Clinical Trial R327 Advances to High Dose Cohort
	RCE RCE Ann: Anti-Viral Patent Granted in Hong Kong
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial
	RCE RCE Ann: $3.08m R&D Rebate Received
	RCE RCE Ann: Safety Committee Clears PhI R327 Dose Increase
	RCE RCE Ann: S&P DJI Announces March 2022 Quarterly Rebalance
	RCE RCE Ann: Appendix 4D and Interim Financial Report
	RCE RCE Ann: Positive Safety Continues in 3rd Cohort PhI Clinical Trial
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Notification regarding unquoted securities - RCE
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: Positive Safety Data from Third Cohort of PI Clinical Trial
	RCE RCE Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RCE RCE Ann: Positive Safety Data from Second Cohort of PI Clinical Trial
	RCE RCE Ann: Positive Safety Data from Phase 1 Clinical Trial
	RCE RCE Ann: Patients to be Dosed in Ph 1 IV Clinical Trial of R327
	RCE RCE Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
	RCE RCE Ann: Results of Meeting
	RCE RCE Ann: AGM Presentation
	RCE RCE Ann: Opening R&D Address at World AMR Congress
	RCE RCE Ann: Appendix 4C and Activity Report
	RCE RCE Ann: Ethics Approval to Start Phase 1 Intravenous Clinical Trial
	RCE RCE Ann: Letter to Shareholders - Annual General Meeting
	RCE RCE Ann: Notice of General Meeting/Proxy Form
	RCE RCE Ann: Reinstatement to Official Quotation
	RCE RCE Ann: Court Orders Granted
	RCE RCE Ann: Suspension from Official Quotation
	RCE RCE Ann: Application for quotation of securities - RCE
	RCE RCE Ann: Court application and delayed cleansing notice
	RCE RCE Ann: Trading halt

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
11-Sep	$0.36	40,381	-0.02 (4.05%)
10-Sep	$0.37	97,134	+0.02 (4.23%)
09-Sep	$0.36	29,672	-0.02 (4.05%)
08-Sep	$0.37	242,532	+0.01 (2.78%)
07-Sep	$0.36	59,963	-0.01 (2.70%)
04-Sep	$0.37	75,875	+0.01 (2.78%)
03-Sep	$0.36	27,753	0.00 (0.00%)
02-Sep	$0.36	41,259	0.00 (0.00%)
01-Sep	$0.36	130,690	-0.02 (4.00%)
31-Aug	$0.38	55,429	+0.01 (2.18%)
28-Aug	$0.37	116,709	-0.01 (2.13%)
27-Aug	$0.38	189,511	-0.01 (1.32%)
26-Aug	$0.38	100,215	+0.01 (1.33%)
25-Aug	$0.38	38,796	+0.01 (1.35%)
24-Aug	$0.37	21,429	+0.01 (1.37%)
7 up, 6 down, and 2 flat days

Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Recce Pharmaceuticals Ltd Health Care Blood Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals